Published in Ann Emerg Med on October 01, 1989
Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care (2004) 5.39
Drug-induced rhabdomyolysis--mechanisms and management. Postgrad Med J (1993) 1.30
Acute renal failure caused by pheniramine maleate induced rhabdomyolysis: an unusual case. Indian J Crit Care Med (2009) 0.92
A case of acute renal failure and compartment syndrome after an alcoholic binge. J Accid Emerg Med (1999) 0.81
Rhabdomyolysis following acute alcohol intoxication. J Accid Emerg Med (1995) 0.80
Case files of the medical toxicology fellowship at Drexel University. Rhabdomyolysis and compartment syndrome following acute diphenhydramine overdose. J Med Toxicol (2011) 0.80
Levofloxacin-induced rhabdomyolysis: a case report. J Med Case Rep (2016) 0.75
Rhabdomyolysis in 114 patients with acute poisonings. J Res Med Sci (2015) 0.75
Ventricular fibrillation and rhabdomyolysis after administration of succinylcholine. Neth Heart J (2003) 0.75
Nephrotoxicity of methadone: a systematic review. Springerplus (2016) 0.75
Nephroprotective effect of ethanolic extract of Azima tetracantha root in glycerol induced acute renal failure in Wistar albino rats. J Tradit Complement Med (2015) 0.75
Pheniramine Maleate-Induced Rhabdomyolysis and Aki: Is it Fatal? Toxicol Int (2015) 0.75
Ann Burns Fire Disasters (2015) 0.75
Survey on Hypothermia and Hyperthermia in Poisoned Patients in a Unique Referral Hospital, Tehran, Iran. Iran Red Crescent Med J (2016) 0.75
A Case of Rhabdomyolysis After Intravenous Heroin Use. Prim Care Companion J Clin Psychiatry (2004) 0.75
T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37
Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell (1997) 2.66
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A (1977) 2.45
An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42
Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med (2012) 2.17
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14
Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 2.08
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (1995) 1.98
Reconciliation of international administrative coding systems for comparison of colorectal surgery outcome. Colorectal Dis (2014) 1.91
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem (1994) 1.88
Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem (1996) 1.87
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology (2000) 1.78
Effects of cisapride on QT interval in children. J Pediatr (1998) 1.59
Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry (1989) 1.55
Ambruticin (W7783), a new antifungal antibiotic. J Antibiot (Tokyo) (1977) 1.52
Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem (1994) 1.51
Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem (1990) 1.51
Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med (1995) 1.49
Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol (1996) 1.49
Acute enlargement and subsequent rupture of an abdominal aortic aneurysm in a patient receiving chemotherapy for pancreatic carcinoma. J Vasc Surg (2000) 1.48
Indirect detection of intraoperative carbon monoxide exposure by mass spectrometry during isoflurane anesthesia. Anesthesiology (1995) 1.44
Maternal recall of infant feeding events is accurate. J Epidemiol Community Health (1992) 1.42
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41
Amino acid sequence of rabbit muscle aldolase and the structure of the active center. Science (1974) 1.32
Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. J Biol Chem (1994) 1.32
Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun (2001) 1.30
Mapping of the active site of recombinant human erythropoietin. Blood (1997) 1.25
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol (1992) 1.24
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg (1998) 1.24
Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol Med (2009) 1.23
Primary structure of cholera toxin subunit A1: isolation, partial sequences and alignment of the BrCN fragments. FEBS Lett (1979) 1.20
Cloning and characterization of B delta, a novel regulatory subunit of protein phosphatase 2A. FEBS Lett (1999) 1.20
A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol (2001) 1.19
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs (1996) 1.19
Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg (1999) 1.17
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg (1995) 1.15
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Transfusion (2004) 1.15
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. Am J Physiol Lung Cell Mol Physiol (2000) 1.15
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ (2000) 1.14
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer (1991) 1.14
Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem (1996) 1.14
Pleuropulmonary melioidosis in a Cambodian refugee. Can Med Assoc J (1984) 1.12
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer (1996) 1.12
Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg (1996) 1.11
CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins. Biochemistry (1988) 1.11
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand (1977) 1.10
Women's health and social change: the case of lay midwives. Int J Health Serv (1988) 1.10
Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain. Arch Biochem Biophys (1991) 1.09
Effect of donor ethnicity on kidney survival in different recipient pairs: an analysis of the OPTN/UNOS database. Transplant Proc (2009) 1.09
Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A (1990) 1.08
Pancreastatin and islet hormone release. Proc Natl Acad Sci U S A (1987) 1.08
Early recognition of atypical Francisella tularensis strains lacking a cysteine requirement. J Clin Microbiol (1994) 1.07
Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology (1998) 1.06
Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood (1988) 1.06
Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle. Gene Ther (1998) 1.05
Thrombolytic therapy: what is its role in free flap salvage? Ann Plast Surg (2001) 1.05
Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera. J Immunol (2000) 1.05
Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg (2000) 1.04
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer (2004) 1.04
Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation. FEBS Lett (2001) 1.04
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer (1999) 1.04
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. Eur J Surg Oncol (2011) 1.04
An analysis of errors in kinematic parameters associated with in vivo functional radiographs. Spine (Phila Pa 1976) (1992) 1.03
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol (1998) 1.02
Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA (1998) 1.02
Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Natl Acad Sci U S A (1994) 1.02
The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J Gen Virol (1999) 1.01
Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. Am J Pathol (1991) 1.01
Anastomotic leak after double-stapled low colorectal resection. Dis Colon Rectum (1996) 1.00
Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology (1981) 0.99
Statin therapy in Alzheimer's disease. Acta Neurol Scand Suppl (2006) 0.99
A Year of Fractures: a snapshot analysis of the logistics, problems and outcomes of a hospital-based fracture liaison service. Osteoporos Int (2013) 0.99
Depressor and natriuretic activities of several atrial peptides. Regul Pept (1984) 0.98
Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol (1993) 0.98
Developmental expression of pulmonary surfactant protein D (SP-D). Am J Respir Cell Mol Biol (1991) 0.98
Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes. Am J Respir Cell Mol Biol (1995) 0.98
Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem (1996) 0.97
Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. Science (1983) 0.97
Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis (1998) 0.96
Carbohydrate modifications of the high mobility group proteins. Proc Natl Acad Sci U S A (1981) 0.96
ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses. J Neurosci (1995) 0.95
Mutations in the putative calcium-binding domain of polyomavirus VP1 affect capsid assembly. J Virol (1993) 0.95
Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: an experimental analysis. J Vasc Surg (2001) 0.94
Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system. J Virol (1997) 0.94
Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms. J Biol Chem (1995) 0.94
Inhibition of gastric acid secretion in dogs by neurotensin. Life Sci (1976) 0.94
HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J Leukoc Biol (1997) 0.94
Phase-sensitive X-ray imaging of synovial joints. Osteoarthritis Cartilage (2009) 0.93
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer (2003) 0.92
Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J Clin Invest (1995) 0.92
Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension. Am Rev Respir Dis (1989) 0.92
In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin. Peptides (1982) 0.92